Skip to content
Search

Latest Stories

GPhC in final stages to declare registration assessment date

The GPhC has said on Tuesday (September 22) that it is in the final stages of the procurement exercise to announce the date of this year’s postponed registration assessment.

The General Pharmaceutical Council (GPhC) further clarified that it will provide further updates on the assessment to all the candidates by the end of this month.


The regulator’s latest update on the registration assessment date follows the joint letter from the British Pharmaceutical Students’ Association (BPSA) and the Royal Pharmaceutical Society (RPS) which urged the GPhC to announce the date of the postponed 2020 registration assessment without delay.

In a response to joint letter, Nigel Clarke, Chair of the GPhC, said: “We want to give candidates clarity about the date of the assessment as soon as possible but cannot confirm an exact date until we have completed the procurement exercise to identify a supplier to provide the online assessment.

“We are now in the very final stages of the procurement exercise and expect to be able to give a further update to all candidates by next week. Once the supplier has been appointed, we will work with them at pace to identify when the registration assessment can be held.

“This is the first time we have held an online assessment and it is a very complex process to move the assessment online. We want to make sure that the new online platform supports all candidates, including those who may need adjustments, to complete the assessment to the best of their abilities.”

Commenting on the response from the regulator, Paul Bennett, RPS Chief Executive, said: “We appreciate this rapid response from the GPhC and are encouraged that they have taken our concerns onboard.  RPS and BPSA will support the GPhC and its trainees in any way we can.”

Regan McCahill, BPSA President, said: ““It is vital that provisionally registered pharmacists, and those who were ineligible for the provisional register, get the answers they need about arrangements for the assessment.

“The prolonged uncertainty and the likelihood that the delay will extend into 2021 is deeply troubling. We very much want to see the GPhC address this as a matter of urgency and would also expect them to communicate more regularly and openly with trainees.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less